Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries

Published:2014-04-02 Issue:7 Volume:41 Page:4713-4720
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Shi Ke-Qing,Wu Fa-Ling,Liu Wen-Yue,Zhao Chen-Chen,Chen Chang-Xi,Xie Yao-Yao,Wu Sheng-Jie,Lin Xian-Feng,Chen Yong-Ping,Wong Danny Ka-Ho,Yuen Man-Fung,Zheng Ming-Hua

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11033-014-3342-z.pdf

Reference31 articles.

1. Fan JG, Farrell GC (2009) Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 50:204–210

2. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124–131

3. David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB (2009) Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49:1904–1912

4. Utzschneider KM, Kahn SE (2006) Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91:4753–4761

5. Kasturiratne A, Weerasinghe S, Dassanayake AS, Rajindrajith S, de Silva AP, Kato N, Wickremasinghe AR, de Silva HJ (2012) Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J Gastroenterol Hepatol 28(1):142–147

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and bioinformatic study on clinical, paraclinical, and genetic factors predisposing to stent restenosis following percutaneous coronary intervention;BMC Cardiovascular Disorders;2024-06-14

2. Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases;Clinical and Molecular Hepatology;2023-01-01

3. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease;Journal of Gastroenterology and Hepatology;2022-02-08

4. Predictive value of using plasma long non‑coding RNAs ANRIL and HOXA11‑AS for in‑stent restenosis;Experimental and Therapeutic Medicine;2021-12-06

5. Cardiovascular comorbidity in patients with nonalcoholic fatty liver disease;Medicine of Extreme Situations;2021-12